Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms… Read more
Hologic Inc (HOLX) - Net Assets
Latest net assets as of December 2025: $5.25 Billion USD
Based on the latest financial reports, Hologic Inc (HOLX) has net assets worth $5.25 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.18 Billion) and total liabilities ($3.94 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.25 Billion |
| % of Total Assets | 57.13% |
| Annual Growth Rate | 35.1% |
| 5-Year Change | 19.66% |
| 10-Year Change | 135.59% |
| Growth Volatility | 2559.82 |
Hologic Inc - Net Assets Trend (1989–2025)
This chart illustrates how Hologic Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hologic Inc (1989–2025)
The table below shows the annual net assets of Hologic Inc from 1989 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $5.05 Billion | -1.60% |
| 2024-09-30 | $5.13 Billion | +2.25% |
| 2023-09-30 | $5.02 Billion | +2.89% |
| 2022-09-30 | $4.88 Billion | +15.59% |
| 2021-09-30 | $4.22 Billion | +55.82% |
| 2020-09-30 | $2.71 Billion | +18.79% |
| 2019-09-30 | $2.28 Billion | -6.16% |
| 2018-09-30 | $2.43 Billion | -12.78% |
| 2017-09-30 | $2.78 Billion | +29.96% |
| 2016-09-30 | $2.14 Billion | +3.05% |
| 2015-09-30 | $2.08 Billion | +0.79% |
| 2014-09-30 | $2.06 Billion | +6.26% |
| 2013-09-30 | $1.94 Billion | -34.43% |
| 2012-09-30 | $2.96 Billion | +0.82% |
| 2011-09-30 | $2.94 Billion | +8.83% |
| 2010-09-30 | $2.70 Billion | +7.40% |
| 2009-09-30 | $2.51 Billion | -45.87% |
| 2008-09-30 | $4.64 Billion | +476.16% |
| 2007-09-30 | $805.72 Million | +33.01% |
| 2006-09-30 | $605.75 Million | +178.08% |
| 2005-09-30 | $217.83 Million | +31.01% |
| 2004-09-30 | $166.28 Million | +11.65% |
| 2003-09-30 | $148.93 Million | +4.58% |
| 2002-09-30 | $142.41 Million | +27.37% |
| 2001-09-30 | $111.81 Million | -15.02% |
| 2000-09-30 | $131.57 Million | -12.52% |
| 1999-09-30 | $150.40 Million | +7.12% |
| 1998-09-30 | $140.40 Million | +10.73% |
| 1997-09-30 | $126.80 Million | +18.17% |
| 1996-09-30 | $107.30 Million | +372.69% |
| 1995-09-30 | $22.70 Million | +14.07% |
| 1994-09-30 | $19.90 Million | +22.09% |
| 1993-09-30 | $16.30 Million | -9.94% |
| 1992-09-30 | $18.10 Million | +8.38% |
| 1991-09-30 | $16.70 Million | +6.37% |
| 1990-09-30 | $15.70 Million | +15600.00% |
| 1989-09-30 | $100.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hologic Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 341200000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $3.41 Billion | 67.58% |
| Common Stock | $3.00 Million | 0.06% |
| Other Comprehensive Income | $-100.80 Million | -2.00% |
| Other Components | $1.73 Billion | 34.35% |
| Total Equity | $5.05 Billion | 100.00% |
Hologic Inc Competitors by Market Cap
The table below lists competitors of Hologic Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bank Hapoalim B.M
PINK:BKHPF
|
$16.61 Billion |
|
BANDAI NAMCO Holdings Inc
PINK:NCBDF
|
$16.62 Billion |
|
Brookfield Infrastructure Partners LP
NYSE:BIP
|
$16.66 Billion |
|
Royal Gold Inc
NASDAQ:RGLD
|
$16.70 Billion |
|
WSP Global Inc
PINK:WSPOF
|
$16.55 Billion |
|
Unimicron Technology Corp
TW:3037
|
$16.54 Billion |
|
Sun Communities Inc
NYSE:SUI
|
$16.50 Billion |
|
MTU Aero Engines AG
PINK:MTUAF
|
$16.50 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hologic Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,130,000,000 to 5,047,900,000, a change of -82,100,000 (-1.6%).
- Net income of 565,700,000 contributed positively to equity growth.
- Share repurchases of 752,900,000 reduced equity.
- Other comprehensive income increased equity by 10,700,000.
- Other factors increased equity by 94,400,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $565.70 Million | +11.21% |
| Share Repurchases | $752.90 Million | -14.92% |
| Other Comprehensive Income | $10.70 Million | +0.21% |
| Other Changes | $94.40 Million | +1.87% |
| Total Change | $- | -1.60% |
Book Value vs Market Value Analysis
This analysis compares Hologic Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.38x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6538.36x to 3.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-09-30 | $0.01 | $75.05 | x |
| 1990-09-30 | $0.56 | $75.05 | x |
| 1991-09-30 | $0.54 | $75.05 | x |
| 1992-09-30 | $0.57 | $75.05 | x |
| 1993-09-30 | $0.52 | $75.05 | x |
| 1994-09-30 | $0.81 | $75.05 | x |
| 1995-09-30 | $0.62 | $75.05 | x |
| 1996-09-30 | $2.14 | $75.05 | x |
| 1997-09-30 | $2.33 | $75.05 | x |
| 1998-09-30 | $2.53 | $75.05 | x |
| 1999-09-30 | $2.64 | $75.05 | x |
| 2000-09-30 | $2.15 | $75.05 | x |
| 2001-09-30 | $1.81 | $75.05 | x |
| 2002-09-30 | $1.86 | $75.05 | x |
| 2003-09-30 | $1.85 | $75.05 | x |
| 2004-09-30 | $1.95 | $75.05 | x |
| 2005-09-30 | $2.41 | $75.05 | x |
| 2006-09-30 | $6.23 | $75.05 | x |
| 2007-09-30 | $7.35 | $75.05 | x |
| 2008-09-30 | $18.87 | $75.05 | x |
| 2009-09-30 | $9.79 | $75.05 | x |
| 2010-09-30 | $10.43 | $75.05 | x |
| 2011-09-30 | $11.11 | $75.05 | x |
| 2012-09-30 | $11.21 | $75.05 | x |
| 2013-09-30 | $7.23 | $75.05 | x |
| 2014-09-30 | $7.41 | $75.05 | x |
| 2015-09-30 | $7.18 | $75.05 | x |
| 2016-09-30 | $7.49 | $75.05 | x |
| 2017-09-30 | $9.75 | $75.05 | x |
| 2018-09-30 | $8.83 | $75.05 | x |
| 2019-09-30 | $8.46 | $75.05 | x |
| 2020-09-30 | $10.22 | $75.05 | x |
| 2021-09-30 | $16.24 | $75.05 | x |
| 2022-09-30 | $19.21 | $75.05 | x |
| 2023-09-30 | $20.16 | $75.05 | x |
| 2024-09-30 | $21.60 | $75.05 | x |
| 2025-09-30 | $22.18 | $75.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hologic Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.21%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.80%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 1.79x
- Recent ROE (11.21%) is below the historical average (40.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | 1400.00% | 12.28% | 2.11x | 54.00x | $1.39 Million |
| 1990 | 16.56% | 13.13% | 0.98x | 1.29x | $1.03 Million |
| 1991 | 4.19% | 4.09% | 0.86x | 1.19x | $-970.00K |
| 1992 | 8.29% | 5.73% | 1.15x | 1.25x | $-310.00K |
| 1993 | -11.04% | -7.26% | 1.12x | 1.36x | $-3.43 Million |
| 1994 | 15.08% | 7.79% | 1.35x | 1.43x | $1.01 Million |
| 1995 | 8.37% | 4.38% | 1.28x | 1.49x | $-370.00K |
| 1996 | 10.62% | 12.93% | 0.72x | 1.15x | $670.00K |
| 1997 | 13.96% | 16.59% | 0.74x | 1.14x | $5.02 Million |
| 1998 | 7.41% | 9.00% | 0.67x | 1.23x | $-3.64 Million |
| 1999 | -2.46% | -4.40% | 0.48x | 1.17x | $-18.74 Million |
| 2000 | -14.15% | -19.86% | 0.43x | 1.67x | $-31.78 Million |
| 2001 | -18.65% | -11.68% | 0.91x | 1.75x | $-32.03 Million |
| 2002 | 0.13% | 0.09% | 1.03x | 1.29x | $-14.06 Million |
| 2003 | 1.94% | 1.41% | 1.08x | 1.27x | $-12.01 Million |
| 2004 | 7.32% | 5.32% | 1.08x | 1.27x | $-4.46 Million |
| 2005 | 12.97% | 9.82% | 1.03x | 1.28x | $6.47 Million |
| 2006 | 4.53% | 5.93% | 0.54x | 1.41x | $-33.15 Million |
| 2007 | 11.74% | 12.81% | 0.69x | 1.32x | $14.01 Million |
| 2008 | -8.31% | -23.03% | 0.21x | 1.75x | $-849.84 Million |
| 2009 | -86.61% | -132.93% | 0.29x | 2.26x | $-2.43 Billion |
| 2010 | -2.33% | -3.74% | 0.30x | 2.08x | $-332.67 Million |
| 2011 | 5.35% | 8.78% | 0.30x | 2.05x | $-136.54 Million |
| 2012 | -2.49% | -3.68% | 0.19x | 3.54x | $-369.74 Million |
| 2013 | -60.41% | -47.06% | 0.28x | 4.64x | $-1.37 Billion |
| 2014 | 0.84% | 0.68% | 0.30x | 4.08x | $-189.00 Million |
| 2015 | 6.33% | 4.87% | 0.35x | 3.69x | $-76.32 Million |
| 2016 | 15.44% | 11.68% | 0.39x | 3.41x | $116.53 Million |
| 2017 | 27.13% | 24.70% | 0.38x | 2.87x | $477.03 Million |
| 2018 | -4.58% | -3.46% | 0.45x | 2.98x | $-354.18 Million |
| 2019 | -1.76% | -1.19% | 0.51x | 2.90x | $-268.11 Million |
| 2020 | 41.22% | 29.53% | 0.52x | 2.66x | $844.68 Million |
| 2021 | 44.36% | 33.23% | 0.63x | 2.11x | $1.45 Billion |
| 2022 | 26.70% | 26.77% | 0.54x | 1.86x | $814.38 Million |
| 2023 | 9.09% | 11.31% | 0.44x | 1.82x | $-45.69 Million |
| 2024 | 15.39% | 19.59% | 0.44x | 1.78x | $276.50 Million |
| 2025 | 11.21% | 13.80% | 0.45x | 1.79x | $60.91 Million |
Industry Comparison
This section compares Hologic Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hologic Inc (HOLX) | $5.25 Billion | 1400.00% | 0.75x | $16.60 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |